// App-Quantinova.ai

EP1122 : THE INCREASING INCIDENCE AND PREVALENCE OF HYPEREOSINOPHILIC SYNDROME (HES) IN THE UK

Researchers

Presenter

  • Gema Requena

Principal Investigators

  • John Logie

  • Daniel Gibbons

  • Jonathan Steinfeld

  • Melissa Van Dyke

Medical Centers

  • Value Evidence and Outcomes Data, Methods and Analytics, Global Medical,GSK,London,United Kingdom

  • Development,GSK,Collegeville,United States

  • Respiratory Research &amp

  • GSK, Collegeville, United States

  • Epidemiology, Value Evidence and Outcomes, Global R&amp

  • GSK, Brentford, United Kingdom

  • Value Evidence and Outcomes Data, Methods and Analytics, Global Medical,GSK,London,United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Hypereosinophilic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A